Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pain, Postoperative 8Breast Neoplasms 6Prostatic Neoplasms 4Lung Neoplasms 4Stomach Neoplasms 3Agnosia 3Pain 2Neoplasms 2Meningioma 2Colorectal Neoplasms 2Supratentorial Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Ganglion Cysts 1Esophageal Neoplasms 1Emergence Delirium 1ENT Cancers 1Cystic Adenomatoid Malformation of Lung, Congenital 1Colonic Neoplasms 1Carpal Tunnel Syndrome 1Cancer Pain 1Bronchopulmonary Sequestration 1

Interventions

Ropivacaine 1Lidocaine 1Infusion Pumps, Implantable 1Calcium Dobesilate 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pain, Intractable × Ropivacaine × Clear all
NCT04085120 2019-09-11

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

All India Institute of Medical Sciences

Phase NA Unknown
60 enrolled
Head & Neck

Cancer Pain, Oropharyngeal Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡